Actively Recruiting
Using Polyglycolic Acid Mesh Prevents Cerebrospinal Fluid Leakage
Led by National Taiwan University Hospital · Updated on 2024-06-25
30
Participants Needed
1
Research Sites
108 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
The papers propose a new method to prevent postoperative cerebrospinal fluid leakage. Doctors use the absorbable polyglycolic acid (PGA) and fibrin glue to repair in surgery, prevent cerebrospinal fluid leakage and reduce the necessity of postoperative lumbar drainage after surgery. This study will analyze the changes in cerebrospinal fluid leakage in patients with pituitary tumors and skull base tumors after surgery, and further understand the effectiveness of Neoveil , as the basis for the development of new treatments.
CONDITIONS
Official Title
Using Polyglycolic Acid Mesh Prevents Cerebrospinal Fluid Leakage
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Patients with primary or recurrent pituitary tumors who require endoscopic nasal surgery
- Patients aged 20 years or older
You will not qualify if you...
- Patients with pituitary gland tumors who are not receiving surgical treatment
- Patients with other brain tumors
- Patients allergic to polyglycolic acid (PGA)
- Patients who have had previous radiation therapy or chemotherapy
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
National Taiwan University Hospital
Taipei, Taiwan, 100
Actively Recruiting
Research Team
A
Abel Huang, MD
CONTACT
A
Abel Huang, MD
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
NA
Model
SINGLE_GROUP
Primary Purpose
TREATMENT
Number of Arms
1
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here